Skip to content
Home/Companies/Biotech/Macro Biologics

Macro Biologics

Biotech·US·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Macro Biologics?

Macro Biologics is currently owned by Oscar & Paul (Beiersdorf Venture Capital) through Oscar & Paul Venture Capital Fund I (2020 vintage), since 2024.

Hand-verified · updated 2026-07-03

Oscar & Paul (Beiersdorf Venture Capital)
Investor
Oscar & Paul (Beiersdorf Venture Capital)
Oscar & Paul Venture Capital Fund I · 2020 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Oscar & Paul Venture Capital Fund I

Other portfolio companies in the same fund.

Turbine
Turbine
Active
Deep TechUK· 2026
Cellvie
Cellvie
Active
BiotechUS· 2025
Melt&Marble
Active
BiotechSweden· 2025
ReVentas
Active
EnergyUK· 2025
Vincere Biosciences
Active
BiotechUS· 2025
DeepLife
Active
Deep TechFrance· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Macro Biologics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Macro Biologics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Macro Biologics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue